WeVote
Log In

Bill

Bill

SB 2967

MENSTRUAL HEALTH-PAID LEAVE

104th Regular Session Introduced by Adriane Johnson

Illinois bill would grant employees paid leave for menstrual health conditions, providing workplace accommodations for severe symptoms affecting work capacity.

Rule 2-10 Committee/3rd Reading Deadline Established As May 22, 2026
0
WeVote Research Nonpartisan
Bill Summary · SB 2967

Legislative bill overview

SB 2967 would establish paid menstrual leave protections in Illinois, allowing employees to take paid time off for menstrual-related health conditions without penalty. The bill addresses workplace accommodations for individuals experiencing severe menstrual symptoms that impact their ability to work.

Why is this important

Menstrual health conditions like dysmenorrhea and menorrhagia can cause debilitating symptoms, yet many workers lack formal workplace protections or accommodations. This legislation aims to reduce stigma around menstrual health and prevent employees from losing pay when managing serious medical conditions. It reflects growing recognition of menstrual equity as a workplace health issue.

Potential points of contention

  • Privacy and disclosure concerns: Employees may face pressure to disclose sensitive health information to qualify for leave, raising questions about privacy protections and potential discrimination
  • Definitional ambiguity: The bill's scope regarding which conditions qualify and severity thresholds could create implementation challenges and disputes over eligibility
  • Business impact and cost: Employers may argue about operational costs, scheduling complexity, and whether existing reasonable accommodation frameworks (ADA, FMLA) already address these needs
  • Equity questions: Critics may question whether condition-specific leave (versus condition-neutral sick leave expansion) is the most equitable approach for all workers with various health conditions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.